Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells

Area of Science:

• Gene therapy
• Virology
• Stem cell biology

Background:

• Lentiviruses offer advantages over oncoretroviruses for gene transfer due to their ability to infect non-dividing cells.
• Hematopoietic stem cells (HSCs) are a key target for gene therapy due to their self-renewal and differentiation potential.

Purpose of the Study:

• To evaluate the efficiency of human immunodeficiency virus type 1 (HIV-1)-based lentivirus vectors for transducing human HSCs.
• To optimize lentivirus vector design for long-term gene expression and cell persistence.

Main Methods:

• Transduction of purified human HSCs using HIV-1-based lentivirus vectors.
• Assessment of transduction efficiency via marker gene expression and PCR analysis of integrated provirus.
• Construction and testing of modified HIV-1 vectors with deletions in Vif and Vpr genes.

Main Results:

• HIV-1-based lentivirus vectors demonstrated high transduction efficiency (>50%) in human HSCs, independent of cell division.
• Vector optimization by deleting Vif and Vpr genes led to improved long-term persistence of transduced cells.
• Stable expression of marker genes was observed in HSCs transduced with optimized vectors.

Conclusions:

• Lentivirus vectors, particularly HIV-1-based systems, are highly effective for gene transfer into human HSCs.
• Vector modifications are crucial for achieving stable, long-term gene expression and cellular persistence in gene therapy applications.
• These findings expand the potential utility of lentivirus vectors in stem cell gene therapy.